Outcome measures for individuals with multiple sclerosis: Recommendations from the American physical therapy association neurology section task force

Physical Therapy

Volumn 94, Issue 5, 2014, Pages 593-608

  Potter, Kirsten ^a   Cohen, Evan T ^b   Allen, Diane D ^c   Bennett, Susan E ^d   Brandfass, Kathi G ^e   Widener, Gail L ^f   Yorke, Amy M ^g  

^a ROCKHURST UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^f SAMUEL MERRITT UNIVERSITY   (United States)

^g UNIVERSITY OF MICHIGAN FLINT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DELPHI STUDY; HEALTH CARE QUALITY; HUMAN; MULTIPLE SCLEROSIS; PEER REVIEW; PHYSIOTHERAPY; TREATMENT OUTCOME;

DELPHI TECHNIQUE; HUMANS; MULTIPLE SCLEROSIS; PEER REVIEW; PHYSICAL THERAPY MODALITIES; QUALITY INDICATORS, HEALTH CARE; TREATMENT OUTCOME;

EID: 84899672981     PISSN: 00319023     EISSN: 15386724     Source Type: Journal    
DOI: 10.2522/ptj.20130149     Document Type: Article

References (93)

1. Jette DU, Halbert J, Iverson C, et al. Use of standardized outcome measures in physical therapist practice: perceptions and applications. Phys Ther. 2009;89:125-135.
2. Kay TM, Myers AM, Huijbregts M. How far have we come since 1992? A comparative survey of physiotherapists' use of outcome measures. Physiother Can. 2001;53: 268-275.
3. Wedge FM, Braswell-Christy J, Brown CJ, et al. Factors influencing the use of outcome measures in physical therapy practice. Physiother Theory Pract. 2012;28: 119-133.
4. Huijbregts M, Myers AM, Kay TM, Gavin T. Systematic outcome measurement in clinical practice: challenges experienced by physiotherapists. Physiother Can. 2002; 54:25-31, 36.
5. Kantarci OH, Weinshenker BG. Natural history of multiple sclerosis. Neurol Clin. 2005;23:17-38.
6. Swingler RJ, Compston DA. The morbidity of multiple sclerosis. Q J Med. 1992;83: 325-337.
7. Freeman J, Morris M, Davidson M, Dodd K. Outcome measures to quantify the effects of physical therapy for people with multiple sclerosis. J Neurol Phys Ther. 2002;26: 139.
8. Hutchinson B, Forwell S, Bennett S, et al. Toward a consensus on rehabilitation outcomes in MS: gait and fatigue. Int J MS Care. 2009;11:67-78.
9. Pearson OR, Busse ME, van Deursen RW, Wiles CM. Quantification of walking mobility in neurological disorders. QJM. 2004;97:463-475.
10. Potter K, Fulk GD, Salem Y, Sullivan J. Outcome measures in neurological physical therapy practice, part I: making sound decisions. J Neurol Phys Ther. 2011;35: 57-64.
11. Provance PC. Physical therapy in multiple sclerosis rehabilitation. Available at: http://www.nationalmssociety.org/msclinical-care-network/clinical-resourcesand- tools/publications/clinical-bulletins/ download.aspx?id_163. Accessed March 20, 2013.
12. Rudick R, Antel J, Confavreux C, et al. Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force. Ann Neurol. 1997;42:379-382.
13. National Multiple Sclerosis Society. Rehabilitation assessment measures in multiple sclerosis. Available at: http://www. nationalmssociety.org/ms-clinical-carenetwork/ clinical-resources-and-tools/corecurriculum/ managing-ms/comprehensivecare/ rehabilitation-/rehabilitation-paradigm/ assessment-intervention/assessmentmeasures/ index.aspx. Accessed March 20, 2013.
14. Neurology Section of the American Physical Therapy Association. Neurology Section outcome measures recommendations. Available at: http://www.neuropt. org/professional-resources/neurology-sec tion-outcome-measures-recommendations. Accessed March 20, 2013.
15. Neurology Section of the American Physical Therapy Association. 2011. Neurologic entry-level curriculum guidelines. Available at: http://www.neuropt.org/profes sional-resources/2011-neurologic-entrylevel- curriculum-guidelines. Accessed March 20, 2013.
16. StrokEDGE Task Force. StrokEDGE recommendations. Available at http://www. neuropt.org/professional-resources/ neurology-section-outcome-measuresrecommendations/ stroke. Accessed March 20, 2013.
17. World Health Organization. Towards a common language for functioning, disability and health: ICF. Available at: http:// www.who.int/classifications/icf/training/ icfbeginnersguide.pdf. Accessed March 20, 2013.
18. Riddle DL, Stratford PW, Singh JA, Strand CV. Variation in outcome measures in hip and knee arthroplasty clinical trials: a proposed approach to achieving consensus. J. Rheumatol. 2009;36:2050-2056.
19. Sharkey SB, Sharples AY. An approach to consensus building using the Delphi technique: developing a learning resource in mental health. Nurse Educ Today. 2001; 21:398-408.
20. Sullivan JE, Crowner BE, Kluding PM, et al. Outcome measures for individuals with stroke: recommendations from the American Physical Therapy Association Neurology Section Task Force. Phys Ther. 2013; 93:1382-1386.
21. De Villiers M, De Villiers P, Kent A. The Delphi technique in health sciences education research. Med Teach. 2005;27:639-643.
22. American Physical Therapy Association, Section on Research. Towards optimal practice: What can we gain from assessment of patient progress with standardized outcome measures? EDGE (Evaluation Database to Guide Effectiveness) Task Force website. Available at: http://www. ptresearch.org/article/104/resources/ researchers/edge-task-force-evaluationdatabase- to-guide-effectiveness. Accessed July 15, 2013.
23. Kurtzke J. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983; 33:1444-1452.
24. Potter K, Allen D, Bennett S, et al. Report and recommendations of the APTA Neurology Section Multiple Sclerosis Outcome Measures Taskforce. Available at: http:// neuropt.org/docs/ms-edge-documents/ final-ms-edge-document.pdf?sfvrsn_4. Accessed March 20, 2013.
25. Portney LG, Watkins MP. Foundations of Clinical Research: Applications to Practice. Upper Saddle River, NJ: Pearson Prentice Hall; 2009.
26. American Physical Therapy Association, Section on Research. EDGE rating forms. Available at: http://www.ptresearch.org/ site/1/EDGE/REVISED%203.20.12/MS%20. EDGE%20formR.docx. Accessed March 20, 2013.
27. Cooper K. A means of assessing maximal oxygen intake. JAMA. 1968;203:201-204.
28. Hobart J, Riazi A, Lamping D, et al. Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12). Neurology. 2003;60:31-36.
29. Butland R, Pang J, Gross E, et al. Two-, six-, and 12-minute walking tests in respiratory disease. BMJ (Clin Res Ed). 1982;284: 1607-1608.
30. Whitney SL, Wrisley DM, Marchetti GF, et al. Clinical measurement of sit-to-stand performance in people with balance disorders: validity of data for the Five-Times- Sit-to-Stand Test. Phys Ther. 2005;85: 1034-1045.
31. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the Six- Minute Walk Test. Am J Respir Crit Care Med. 2002;166:111-117.
32. Heller A, Wade D, Wood V, et al. Arm function after stroke: measurement and recovery over the first three months. J Neurol Neurosurg Psychiatry. 1987;50: 714-719.
33. Powell LE, Myers AM. The Activitiesspecific Balance Confidence (ABC) Scale. J Gerontol A Biol Sci. 1995;50:M28-M34.
34. Horak FB, Wrisley DM, Frank J. The Balance Evaluation Systems Test (BESTest) to differentiate balance deficits. Phys Ther. 2009;89:484-498.
35. Berg K. Measuring balance in the elderly: preliminary development of an instrument. Physiother Can. 1989;41:304-311.
36. Frenette B, Mergler D, Ferraris J. Measurement precision of a portable instrument to assess vibrotactile perception threshold. Eur J Appl Physiol Occup Physiol. 1990; 61:386-391.
37. Desrosiers J, Bravo G, Hebert R, et al. Validation of the Box and Block Test as a measure of dexterity of elderly people: reliability, validity, and norms studies. Arch Phys Med Rehabil. 1994;75:751-755.
38. Mendoza T, Wang X, Cleeland C, et al. The rapid assessment of fatigue severity in cancer patients. Cancer. 1999;85:1186-1196.
39. Law M, Baptiste S, McColl M, et al. The Canadian Occupational Performance Measure: an outcome measure for occupational therapy. Can J Occup Ther. 1990; 57:82-87.
40. Shumway-Cook A, Horak FB. Assessing the influence of sensory interaction on balance: suggestion from the field. Phys Ther. 1986;66:1548-1550.
41. Hohol MJ, Orav EJ, Weiner H. Disease steps in multiple sclerosis: a simple approach to evaluate disease progression. Neurology. 1995;45:251-255.
42. Jacobson G, Newman C. The development of the Dizziness Handicap Inventory. Arch Otolaryngol Head Neck Surg. 1990;116: 424-427.
43. Shumway-Cook A, Woollacott MH. Motor Control: Theory and Practical Applications. Philadelphia, PA: Williams & Wilkins; 1995.
44. Iriarte J, Katsamakis G, de Castro P. The Fatigue Descriptive Scale (FDS): a useful tool to evaluate fatigue in multiple sclerosis. Mult Scler. 1999;5:10-16.
45. Penner I, Raselli C, Stöcklin M, et al. The Fatigue Scale for Motor and Cognitive Functions (FSMC): validation of a new instrument to assess multiple sclerosisrelated fatigue. Mult Scler. 2009;15:1509-1517.
46. Dite W, Temple V. A clinical test of stepping and change of direction to identify multiple falling older adults. Arch Phys Med Rehabil. 2002;83:1566-1571.
47. Rose DJ, Lucchese N, Wiersma LD. Development of a multidimensional balance scale for use with functionally independent older adults. Arch Phys Med Rehabil. 2006;87:1478-1485.
48. Gorman S, Radtka S, Melnick M, et al. Development and validation of the Function in Sitting Test in adults with acute stroke. J Neurol Phys Ther. 2010;34:150-160.
49. Cella D, Dineen K, Arnason B, et al. Validation of the Functional Assessment of Multiple Sclerosis quality of life instrument. Neurology. 1996;47:129-139.
50. Wrisley DM, Marchetti GF, Kuharsky DK, Whitney SL. Reliability, internal consistency, and validity of data obtained with the functional gait assessment. Phys Ther. 2004;84:906-918.
51. Keith R, Granger C. The Functional Independence Measure: a new tool for rehabilitation. Adv Clin Rehabil. 1987;1:6-18.
52. Duncan PW, Weiner DK, Chandler J, Studenski S. Functional reach: a new clinical measure of balance. J Gerontol. 1990; 45:M192-M197.
53. Turner-Stokes L. Goal attainment scaling (GAS) in rehabilitation: a practical guide. Clin Rehabil. 2009;23:362-370.
54. Sharrack B, Hughes RA. The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis. Mult Scler. 1999;5:223-233.
55. Hauser S, Dawson D, Lehrich J, et al. Intensive immunosuppression in progressive multiple sclerosis: a randomized, threearm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. N Engl J Med. 1983;308:173-180.
56. Williams G, Robertson V, Greenwood K, et al. The High-Level Mobility Assessment Tool (HiMAT) for traumatic brain injury, part 1: item generation. Brain Inj. 2005; 19:925-932.
57. Williams G, Robertson V, Greenwood K, et al. The High-Level Mobility Assessment Tool (HiMAT) for traumatic brain injury, part 2: content validity and discriminability. Brain Inj. 2005;19:833-843.
58. American Thoracic Society/European Respiratory Society. ATS/ERS statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002;166:518-624.
59. American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription. Philadelphia, PA: Lippincott Williams & Wilkins; 2013.
60. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987;67: 206-207.
61. Fischer J, LaRocca N, Miller D, et al. Recent developments in the assessment of quality of life in multiple sclerosis (MS). Mult Scler. 1999;5:251-259.
62. Smith-Wheelock M, Shepard NT, Telian SA. Physical therapy program for vestibular rehabilitation. Am J Otol. 1991;12:218-225.
63. Allen DD. Validity and reliability of the Movement Ability Measure: a self-report instrument proposed for assessing movement across diagnoses and ability levels. Phys Ther. 2007;87:899-916.
64. Paul RH, Beatty WW, Schneider R, et al. Cognitive and physical fatigue in multiple sclerosis: relations between self-report and objective performance. Appl Neuropsychol. 1998;5:143-148.
65. Fischer J, Rudick R, Cutter G, Reingold S. The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment. Mult Scler. 1999;5:244-250.
66. Hobart J, Lamping D, Fitzpatrick R, et al. The Multiple Sclerosis Impact Scale (MSIS- 29): a new patient-based outcome measure. Brain. 2001;124:962-973.
67. Simeoni M, Auquier P, Fernandez O, et al; MusiQol Study Group. Validation of the Multiple Sclerosis International Quality of Life Questionnaire. Mult Scler. 2008;14: 219-230.
68. Vickrey B, Hays R, Harooni R, et al. A health-related quality of life measure for multiple sclerosis. Qual Life Res. 1995;4: 187-206.
69. Hobart J, Riazi A, Thompson A, et al. Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88). Brain. 2006;129:224-234.
70. Galer B, Jensen M. Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology. 1997;48:332-338.
71. Stolk-Hornsveld F, Crow J, Hendriks E, et al. The Erasmus MC modifications to the (revised) Nottingham Sensory Assessment: a reliable somatosensory assessment measure for patients with intracranial disorders. Clin Rehabil. 2006;20:160-172.
72. Finch E, Brooks D, Stratford PW. Physical Rehabilitation Outcome Measures: A Guide to Enhanced Clinical Decision Making. Hamilton, Ontario, Canada: BC Decker Inc; 2002.
73. Steven M, Capell H, Sturrock R, MacGregor J. The physiological cost of gait (PCG): a new technique for evaluating nonsteroidal anti-inflammatory drugs in rheumatoid arthritis. Rheumatology. 1983; 22:141-145.
74. Winward CE, Halligan PW, Wade DT. The Rivermead Assessment of Somatosensory Performance (RASP): standardization and reliability data. Clin Rehabil. 2002;16: 523-533.
75. Collen F, Wade D, Robb G, Bradshaw C. The Rivermead Mobility Index: a further development of the Rivermead Motor Assessment. Disabil Rehabil. 1991;13:50-54.
76. Schmitz-Hübsch T, du Montcel ST, Baliko L, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66:1717-1720.
77. Sipe JC, Knobler RL, Braheny SL, et al. A neurologic rating scale (NRS) for use in multiple sclerosis. Neurology. 1984;34: 1368-1372.
78. Bell JA. Semmes-Weinstein monofilament testing for determining cutaneous light touch/deep pressure sensation. The Star/ Carville. 1984;44(2).
79. Brazier JE, Harper R, Jones NM, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305:160-164.
80. Frzovic D, Morris M, Vowels L. Clinical tests of standing balance: performance of persons with multiple sclerosis. Arch Phys Med Rehabil. 2000;81:215-221.
81. Haugh A, Pandyan A, Johnson G. A systematic review of the Tardieu Scale for the measurement of spasticity. Disabil Rehabil. 2006;28:899-907.
82. Schwid S, Goodman A, Mattson D, et al. The measurement of ambulatory impairment in multiple sclerosis. Neurology. 1997;49:1419-1424.
83. Shumway-Cook A, Brauer S, Woollacott M. Predicting the probability for falls in community-dwelling older adults using the Timed Up & Go Test. Phys Ther. 2000; 80:896-903.
84. Tinetti ME, Richman D, Powell L. Falls efficacy as a measure of fear of falling. J Gerontol. 1990;45:P239-P243.
85. Tinetti ME. Performance-oriented assessment of mobility problems in elderly patients. J Am Geriatr Soc. 1986;34:119-126.
86. Collin C, Wade D. Assessing motor impairment after stroke: a pilot reliability study. J Neurol Neurosurg Psychiatry. 1990;53: 576-579.
87. Verheyden G, Kersten P. Investigating the internal validity of the Trunk Impairment Scale (TIS) using Rasch analysis: the TIS 2.0. Disabil Rehabil. 2010;32:2127-2137.
88. Verheyden G, Nieuwboer A, Mertin J, et al. The Trunk Impairment Scale: a new tool to measure motor impairment of the trunk after stroke. Clin Rehabil. 2004;18: 326-334.
89. Kos D, Nagels G, D'Hooghe MB, et al. A rapid screening tool for fatigue impact in multiple sclerosis. BMC Neurol. 2006;6:27.
90. Neurology Section of the American Physical Therapy Association. Multiple sclerosis. Available at: http://www.neuropt.org/ professional-resources/neurology-sectionoutcome- measures-recommendations/ multiple-sclerosis. Accessed March 20, 2013.
91. American Physical Therapy Association. Functional limitation reporting under medicare. Available at: http://www.apta.org/payment/medicare/codingbilling/functionallimitation/. Accessed July 15, 2013.
92. US Department of Health and Human Services. Implementing the claims-based data collection requirement for outpatient therapy services-section 3005(g) of the Middle Class Tax Relief and Jobs Creation Act (MCTRJCA) of 2012. Available at: http:// www.cms.gov/outreach-and-education/ medicare-learning-network-mln/ m l n m a t t e r s a r t i c l e s/d o w n l o a d s/MM8005.pdf. Accessed July 15, 2013.
93. Rehabilitation Measures Database. Available at: http://www.rehabmeasures.org/default.aspx. Accessed March 20, 2013.